Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Douglas E. ColtharpExec. VP & CFO | -27,69k | 2,05M | Derivative Exercise and Sale | 32,94 - 107,28 | 260,24k | - |
| 2026-05-11 | Mr. Patrick W. TuerExec. VP & COO | -682,00 | 71,31k | Verkauf | 104,56 | 24,76k | -2,68% |
| 2026-03-09 | Mr. Edmund M. FaySenior VP & Treasurer | -11,94k | 1,28M | Verkauf | 107,00 | 86,33k | -12,15% |
| 2026-03-09 | Mr. Edmund M. FaySenior VP & Treasurer | -3,00k | 0,00 | Other Disposition | - | 86,33k | -3,36% |
| 2026-02-28 | Mr. Andrew L. PriceSenior VP & CAO | -307,00 | 33,12k | Sale to Issuer | 107,88 | 74,69k | -0,41% |
| 2026-02-28 | Mr. Edmund M. FaySenior VP & Treasurer | -280,00 | 30,21k | Sale to Issuer | 107,88 | 101,26k | -0,28% |
| 2026-02-28 | Dr. Elissa Joy CharbonneauChief Medical Officer | -369,00 | 39,81k | Sale to Issuer | 107,88 | 17,64k | -2,05% |
| 2026-02-28 | Mr. John Patrick DarbyExec. VP, General Counsel & Corporate Secretary | -416,00 | 44,88k | Sale to Issuer | 107,88 | 83,95k | -0,49% |
| 2026-02-28 | Mr. Mark J. TarrCEO, President & Director | -2,19k | 235,93k | Sale to Issuer | 107,88 | 440,96k | -0,49% |
| 2026-02-28 | Mr. Patrick W. TuerExec. VP & COO | -545,00 | 58,79k | Sale to Issuer | 107,88 | 25,44k | -2,10% |
| 2026-02-28 | Mr. Douglas E. ColtharpExec. VP & CFO | -776,00 | 83,71k | Sale to Issuer | 107,88 | 260,24k | -0,30% |
| 2026-02-23 | Mr. Mark J. TarrCEO, President & Director | -2,49k | 264,10k | Sale to Issuer | 106,15 | 443,15k | -0,56% |
| 2026-02-23 | Mr. Edmund M. FaySenior VP & Treasurer | -380,00 | 40,34k | Sale to Issuer | 106,15 | 101,54k | -0,37% |
| 2026-02-23 | Mr. Patrick W. TuerExec. VP & COO | -506,00 | 53,71k | Sale to Issuer | 106,15 | 25,98k | -1,91% |
| 2026-02-23 | Mr. Douglas E. ColtharpExec. VP & CFO | -14,82k | 1,57M | Sale to Issuer | 106,15 | 261,01k | -5,37% |
| 2026-02-23 | Mr. Andrew L. PriceSenior VP & CAO | -404,00 | 42,88k | Sale to Issuer | 106,15 | 75,00k | -0,54% |
| 2026-02-23 | Dr. Elissa Joy CharbonneauChief Medical Officer | -440,00 | 46,71k | Sale to Issuer | 106,15 | 18,01k | -2,38% |
| 2026-02-23 | Mr. John Patrick DarbyExec. VP, General Counsel & Corporate Secretary | -6,99k | 741,99k | Sale to Issuer | 106,15 | 84,36k | -7,65% |
| 2026-02-19 | Dr. Elissa Joy CharbonneauChief Medical Officer | -4,30k | 460,89k | Sale to Issuer | 106,55 - 107,15 | 18,45k | -18,91% |
| 2026-02-19 | Mr. Mark J. TarrCEO, President & Director | -45,18k | 4,84M | Sale to Issuer | 106,55 - 107,15 | 445,64k | -9,20% |
| 2026-02-19 | Mr. Edmund M. FaySenior VP & Treasurer | -3,69k | 394,94k | Sale to Issuer | 106,55 - 107,15 | 101,92k | -3,49% |
| 2026-02-19 | Mr. Andrew L. PriceSenior VP & CAO | -3,92k | 419,89k | Sale to Issuer | 106,55 - 107,15 | 75,41k | -4,94% |
| 2026-02-19 | Mr. John Patrick DarbyExec. VP, General Counsel & Corporate Secretary | -8,23k | 881,75k | Sale to Issuer | 106,55 - 107,15 | 91,35k | -8,27% |
| 2026-02-19 | Mr. Douglas E. ColtharpExec. VP & CFO | -17,38k | 1,86M | Sale to Issuer | 106,55 - 107,15 | 275,83k | -5,93% |
| 2026-02-19 | Mr. Patrick W. TuerExec. VP & COO | -3,60k | 385,28k | Sale to Issuer | 106,55 - 107,15 | 26,49k | -11,96% |
| 2026-02-11 | Mr. Mark J. TarrCEO, President & Director | -150,00k | 16,75M | Verkauf | 108,03 - 113,58 | 377,07k | -28,46% |
| 2026-02-10 | Mr. Patrick W. TuerExec. VP & COO | -2,80k | 301,77k | Verkauf | 107,62 | 16,04k | -14,88% |
| 2025-08-27 | Mr. Patrick W. TuerExec. VP & COO | -1,02k | 126,06k | Verkauf | 123,59 | 18,85k | -5,13% |
| 2025-08-21 | Mr. Douglas E. ColtharpExec. VP & CFO | -27,48k | 0,00 | Other Disposition | - | 251,20k | -9,86% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
